Verastem IncVSTM
Price$8.05

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $87.5M+3,271.6% YoYTTM through 30 Jun 2026
Net Income -$202.7MTTM through 30 Jun 2026
Free Cash Flow -$162.2MTTM through 30 Jun 2026

Margins

Current
Gross Margin83.7%
EBITDA Margin-181.9%
Operating Margin-240.5%
Net Margin-231.6%

Returns

-237.3%ROE
-85.2%ROA

Balance Sheet Health

Debt / Equity0.89x
Current Ratio2.94x
Net Debt-$108.8Mnet cash position
Cash & Equivalents$136.4M

Quality Metrics

Altman Z-Score-7.04
Piotroski F-Score2 / 9
FCF Margin-185.3%
Rule of 40-152.3
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'21'22'24'25
FY2025: $30.9M
Diluted EPS-$2.42TTM
'19'20'21'22'23'24'25
FY2025: $-3.02

Dividend

No dividend

Capital Allocation

Capex Intensity0.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.